Publications by authors named "Daniel Present"

Claim this Profile
C
Chromoendoscopy Is More Effective Than Standard Colonoscopy in Detecting Dysplasia During Long-term Surveillance of Patients With Colitis.
James F Marion, Jerome D Waye, Yuriy Israel, Daniel H Present, Maria Suprun

Clin Gastroenterol Hepatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6-Mercaptopurine/Azathioprine remains an important contributor in managing Crohn's disease.
Burton I Korelitz, Daniel H Present

J Crohns Colitis· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognosis of lymphoma in patients following treatment with 6-mercaptopurine/azathioprine for inflammatory bowel disease.
Keith Sultan, Burton I Korelitz, Daniel Present, Seymour Katz, Suzanne Sunday

Inflamm Bowel Dis· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis.
Mark Lazarev, Daniel H Present, Simon Lichtiger, Asher Kornbluth, James Marion

J Clin Gastroenterol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term infliximab maintenance therapy for ulcerative colitis: the ACT-1 and -2 extension studies.
Walter Reinisch, William J Sandborn, Paul Rutgeerts, Brian G Feagan, Daniel Rachmilewitz, Daniel Present

Inflamm Bowel Dis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis.
Jean Frédéric Colombel, Paul Rutgeerts, Walter Reinisch, Dirk Esser, Yanxin Wang, Daniel Present

Gastroenterology· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of 22 genetic variants with Crohn's disease risk in the Ashkenazi Jewish population: a case-control study.
Inga Peter, Adele A Mitchell, Laurie Ozelius, Monica Erazo, Jianzhong Hu, Daniel H Present

BMC Med Genet· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice patterns in the use of anti-tumor necrosis factor alpha agents in the management of Crohn's disease: a US national practice survey comparing experts and non-experts.
Arun Swaminath, Benjamin Lebwohl, Kristina M Capiak, Daniel H Present

Dig Dis Sci· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine is safe and effective in patients with severe ulcerative colitis.
Adam S Cheifetz, Joshua Stern, Sagar Garud, Eric Goldstein, Lisa Malter, Daniel H Present

J Clin Gastroenterol· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab.
William J Sandborn, Paul Rutgeerts, Brian G Feagan, Walter Reinisch, Allan Olson, Daniel Present

Gastroenterology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging issues in ulcerative colitis and ulcerative proctitis: individualizing treatment to maximize outcomes.
Stephen B Hanauer, Daniel H Present, David T Rubin

Gastroenterol Hepatol (N Y)· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclosporine and infliximab as rescue therapy for each other in patients with steroid-refractory ulcerative colitis.
Elana A Maser, Deepthi Deconda, Simon Lichtiger, Thomas Ullman, Daniel H Present

Clin Gastroenterol Hepatol· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening and surveillance colonoscopy in chronic Crohn's colitis: results of a surveillance program spanning 25 years.
Sonia Friedman, Peter H Rubin, Carol Bodian, Noam Harpaz, Daniel H Present

Clin Gastroenterol Hepatol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromoendoscopy-targeted biopsies are superior to standard colonoscopic surveillance for detecting dysplasia in inflammatory bowel disease patients: a prospective endoscopic trial.
James F Marion, Jerome D Waye, Daniel H Present, Yuriy Israel, Carol Bodian

Am J Gastroenterol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes.
Deepa Reddy, Seamus J Murphy, Sunanda V Kane, Daniel H Present, Asher A Kornbluth

Am J Gastroenterol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with the use of cyclosporine in patients with inflammatory bowel disease.
Michael B Sternthal, Seamus J Murphy, James George, Asher Kornbluth, Simon Lichtiger, Daniel H Present

Am J Gastroenterol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
James D Lewis, Gary R Lichtenstein, Julius J Deren, Bruce E Sands, Stephen B Hanauer, Daniel H Present

Gastroenterology· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pouch-ouch.
Elana A Maser, Daniel H Present

Curr Opin Gastroenterol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
Kim L Isaacs, Robert S Sandler, Maria Abreu, Michael F Picco, Stephen B Hanauer, Daniel Present

Inflamm Bowel Dis· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy.
Naris Nilubol, Ellen Scherl, David S Bub, Stephen R Gorfine, James Marion, Daniel Present

Dis Colon Rectum· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natalizumab for the treatment of active Crohn's disease: results of the ENCORE Trial.
Stephan R Targan, Brian G Feagan, Richard N Fedorak, Bret A Lashner, Remo Panaccione, Daniel H Present

Gastroenterology· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab for induction and maintenance therapy for ulcerative colitis.
Paul Rutgeerts, William J Sandborn, Brian G Feagan, Walter Reinisch, Allan Olson, Daniel Present

N Engl J Med· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing therapy in patients with pancolitis.
Carmen Cuffari, Daniel H Present, Theodore M Bayless, Gary R Lichtenstein

Inflamm Bowel Dis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is perianal Crohn's disease associated with intestinal fistulization?
David B Sachar, Carol A Bodian, Eric S Goldstein, Daniel H Present, Theodore M Bayless

Am J Gastroenterol· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus conference: Colorectal cancer screening and surveillance in inflammatory bowel disease.
Steven H Itzkowitz, Daniel H Present,

Inflamm Bowel Dis· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis